0001104659-22-030184.txt : 20220303 0001104659-22-030184.hdr.sgml : 20220303 20220303192133 ACCESSION NUMBER: 0001104659-22-030184 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harshbarger Benjamin CENTRAL INDEX KEY: 0001653133 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 22711313 MAIL ADDRESS: STREET 1: ONE MAIN STREET, SUITE 800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Astria Therapeutics, Inc. CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HIGH STREET STREET 2: 28TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: 100 HIGH STREET STREET 2: 28TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: CATABASIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090127 4 1 tm228319-5_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-03-01 0 0001454789 Astria Therapeutics, Inc. ATXS 0001653133 Harshbarger Benjamin C/O ASTRIA THERAPEUTICS, INC., 100 HIGH STREET, FLOOR 28 BOSTON MA 02110 0 1 0 0 Chief Legal Officer Stock Option (right to buy) 6.51 2022-03-01 4 A 0 55000 0 A Common Stock 55000 55000 D This option was granted on March 1, 2022 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 17, 2022 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month. /s/ Benjamin Harshbarger 2022-03-03